PuSH - Publication Server of Helmholtz Zentrum München

Bornstein, S.R. ; Rubino, F.* ; Ludwig, B. ; Rietzsch, H.* ; Schwarz, P.E. ; Rodionov, R.N.* ; Khunti, K.* ; Hopkins, D.* ; Birkenfeld, A.L. ; Bohm, B.* ; Amiel, S.* ; Holt, R.I.G.* ; Skyler, J.S.* ; deVries, J.H.* ; Renard, E.* ; Eckel, R.H.* ; Zimmet, P.* ; Alberti, K.G.* ; Geloneze, B.* ; Chan, J.C.* ; Mbanya, J.C.* ; Onyegbutulem, H.C.* ; Spinas, G.A.* ; Beuschlein, F.* ; Mingrone, G.*

Consequences of the COVID-19 pandemic for patients with metabolic diseases.

Nat. Metab. 3, 289-292 (2021)
Postprint DOI PMC
Open Access Green
The COVID-19 pandemic has stretched healthcare resources and caused severe knock-on effects on patients with metabolic diseases worldwide. We encourage clinicians and patient-interest groups in the field of diabetes and metabolism to raise their voices to ensure adequate care and admission of patients.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Other: Opinion
Corresponding Author
ISSN (print) / ISBN 2522-5812
e-ISSN 2522-5812
Quellenangaben Volume: 3, Issue: 3, Pages: 289-292 Article Number: , Supplement: ,
Publisher Springer
Publishing Place London
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Pancreatic Islet Research (IPI)
Institute of Diabetes Research and Metabolic Diseases (IDM)